Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Invitation to presentation of Bravida’s reportfor the third quarter 2018 on the 6th of November

Bravida’s report for the third quarter 2018 will be published 07:30 CET on the 6th of November.The report will be presented at 09:30 CET by CEO and Group President Mattias Johansson and CFO Nils-Johan Andersson. The presentation will be held in English and can be followed on the web or over the phone. There will be room for questions. Link to the webcast:https://tv.streamfabriken.com/bravida-q3-2018 Telephone numbers for telephone conference:SE: +46 8 5033 65 63UK: +44 20 3008 9809US: +1 855 831 59 47 The report and the presentation will be available on www.bravida.se/en/

Nokian Tyres: Disclosure under chapter 9, section 10 of the securities market act

Nokian Tyres plc Stock Exchange Release October 15, 2018, at 9:50 a.m.  Nokian Tyres has received an announcement from BlackRock, Inc. on October 12, 2018, in accordance with the Finnish Securities Market Act Chapter 9, Section 5. According to the announcement, the total number of Nokian Tyres shares owned by BlackRock, Inc. and its funds exceeded level of 5% of the share capital in Nokian Tyres plc, as result of share transactions concluded on October 11, 2018. BlackRock, Inc. and its funds held on deal date a total of 7,032,123 Nokian Tyres’ shares representing 5.09% of company’s

Inhalation Sciences' news roundup: 2.4 MSEK  sale, new patent, upcoming China installation

With a major 2.4 MSEK sale, a new European patent and the upcoming installation of ISAB's first PreciseInhale system in China - September and October have been eventful and dynamic for Sweden's inhalation R&D innovators.ZICCUM AB SHARE ISSUE OVERSUBSCRIBED 234% before listing on Spotlight ISAB spinout company Ziccum attracted 1,000 new shareholders ahead of its listing on Spotlight. Ziccum's technology can formulate liquid biologic therapies and vaccines - as dry powders. Making them more cost-effective and easy-to-transport. CEO Göran Conradson: "It's gratifying that the new issue has

New CCO to reinforce Ripasso Energy

Swedish clean tech company Ripasso Energy AB has appointed Sven Ljungberg in the role of Chief Communication Officer (CCO) and management team member. The appointment is a step towards further reinforcing the organisation and adapting the company ahead of the planned listing on a regulated marketplace.Ripasso Energy AB has appointed Sven Ljungberg in the newly-established role of CCO. Sven has a sound managerial background, has been working in communication in various roles for almost 30 years, and has substantial experience from several sectors and markets. Sven joins the company from a

New supplementary Strangvac study demonstrates immunological memory with long duration

The Swedish biotechnology company Intervacc has now taken another step towards confirming the effect of its vaccine, one of the company's development development projects, against the infamous streptococcal infection strangles in the horse. A new supplementary study shows that horses vaccinated with the vaccine Strangvac maintain an "immunological memory" against the disease 12 months after vaccination. The result of the study means that a re-vaccination within 12 months, instead of previously shown 6 months, after basic vaccination very quickly restores a protection. Strangles is a

Organizational changes at ChromoGenics

CFO Susanne Andersson leaves ChromoGenics AB (publ) at her own request.Susanne remains in her current role during the term of notice of up to 6 months. ChromoGenics has initiated the recruitment process to find a new CFO. "Susanne has played an important part and successfully contributed to the formation of the company ChromoGenics is today. I thank Susanne for her efforts and congratulate her to the new challenges," says Jerker Lundgren, CEO ChromoGenics. "It has been an exciting time and it has not been an easy decision to leave the company and my colleagues at a time when it seems

Pricer AB appoints Susanne Andersson as new CFO

Susanne Andersson, currently CFO at First North-listed technology company ChromoGenics, has been recruited to the position as CFO for Pricer. In addition to a solid experience of various finance functions in listed companies, Susanne has many years of experience from investor relations for companies such as Ericsson. Susanne will take office no later than April 2019. Current acting CFO, Magnus Midgard, will remain in the company in the role of Head of Finance. For further information, please contact:Helena Holmgren, CEO, Pricer AB, +46 70 2870068 Pricer, founded in 1991 in

Medivir to focus on its clinical development and appoints Uli Hacksell as acting CEO

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) announced today its plans to concentrate its activities on clinical development. As a result, the board has appointed Dr. Uli Hacksell as the company’s acting CEO. Dr. Hacksell, currently on the board of Medivir, succeeds Christine Lind as of today, October 15. “Medivir has a very strong clinical portfolio with inflection points in the near future that are crucial for optimizing its value. This calls for a firm management that is able to reinforce the focus on clinical development throughout the company,” says Anna Malm Bernsten,

Kallelse till extra bolagsstämma i TargetEveryOne AB (publ)

Aktieägarna i TargetEveryOne AB (publ), org. nr. 556526-6748 (”Bolaget”), kallas härmed till extra bolagsstämma den 13 november 2018 klockan 10 på Kungsgatan 37, 8 tr. i Stockholm. Aktieägare som vill delta i stämman ska dels vara införda i den av Euroclear Sweden AB förda aktieboken den 7 november 2018, dels anmäla sitt deltagande till Bolaget senast den 7 november 2018, per post till adress TargetEveryOne AB, Prästgatan 18 A, 1 tr, 111 29 Stockholm, eller per e-post (e-post_info@targeteveryone.com) info@targeteveryone.com. Vid anmälan anges namn, adress, telefonnummer, person- eller

Analysguiden: Looking for a golden exit

Kopy Goldfields is raising capital to prepare for a possible divestment of its share in the Krasny project. Recent progress in the projects, a low subscription price and the prospect for a near-term divestment are factors supportive to the case.Following exploration results in 2017 and 2018, gold resources in Kopy Goldfields’ flag ship project Krasny have increased by 32 percent to 1,84 Moz. Kopy Goldfields and Russian Partner GV Gold have agreed on a budget to finance a sale process for the project for marketing to external buyers. We believe this is constructive news, as the path forward

Nixu Corporation’s revenue information for Q3 2018

Nixu CorporationPress release, October 15, 2018 at 9:05 AM EESTEuropean cybersecurity company Nixu publishes annually a half-year financial report, financial statements and provides revenue information of the first and the third quarter in accordance with its disclosure policy. Nixu has announced today its revenue information for the third quarter 2018. Nixu Corporation's unaudited revenue for July–September 2018 was EUR 8.4 million. Nixu repeats its financial guidance for 2018: Nixu will strive to continue its growth faster than its market while maintaining profitability. Nixu’s

Cinclus Pharma abstract selected Poster of Excellence at the UEGW conference

The Basel, Switzerland-based biotech company Cinclus Pharma AG today announced that its abstract P1152 was selected Poster of Excellence at the upcoming United European Gastroenterology Week, which is the largest annual meeting in Europe focused on GI-related diseases. The conference will be held in Vienna, Austria, October 20-24.The poster presentation will be given by Kjell Andersson, CEO at Cinclus Pharma AG, and Peter Unge, CMO at Cinclus Pharma AG, on October 23 at 12.30pm – 1.30pm.The title of Abstract P1152 is: THE NEW P-CAB X482 WAS SAFE, TOLERABLE AND PROVIDED 24H INTRAGASTRIC

Handelsbanken’s interim report for January-September 2018 will be presented on October 24

Handelsbanken will present its results for January­‑September 2018 in Stockholm on October 24, 2018, at 8:15 a.m. CET, at a meeting with the media and analysts. The interim report for January‑September 2018 will be published at 6:45 a.m. CET, on October 24, 2018. A telephone conference will be held at 11:15 a.m. CET (5:15 a.m. EST), when Rolf Marquardt, CFO, will present and comment on the results. There will also be time for questions from the participants. UK number: +44 20–3008 9801Swedish number: +46 8–566 426 90US number: +1 855–8315 948 Instructions1.     Dial +xx

Invitation to presentation of Inwido´s interim report on October 23

Inwido, Europe’s largest supplier of windows and a leading door supplier, will publish its third quarter results on October 23, 2018 at 07:45 am CET.A conference call for investors, analysts and media will be held at 10.00 (CET) that same day. The report will be presented by Håkan Jeppsson, President and CEO and Peter Welin, CFO. The presentation will be held in English and will also be live webcasted at; http://www.inwido.com/investors/financial-reports-and-presentations. Here you will also find the presentation material for the meeting before it starts. It will also be possible to take

Cxense appoints Jørgen Evjen as Chief Financial Officer

Oslo, Norway – 15 October 2018 - Cxense ASA (OSE: CXENSE) today announced that Jørgen Evjen has been appointed Chief Financial Officer (CFO) of the company. He is expected to join the company in February 2019.  Jørgen is an experienced finance manager and leader, having held senior positions at circular economy company Norsk Gjenvinning, smart grid technology provider Enfo Energy and mobile applications company Numo Solutions. He also has a background as corporate finance advisor at the Nordic investment bank Carnegie AB. Jørgen has worked extensively with business strategy, governance

Heimstaden Bostad AB has engaged a rating institute and advisory banks

Heimstaden ABs subsidiary, Heimstaden Bostad AB, has engaged Standard & Poor´s for an official raiting.  "Heimstaden Bostad aims to achieve an investment grade rating and we are working towards this”, says Magnus Nordholm, deputy CEO of Heimstaden AB. Heimstaden Bostad AB has also engaged Danske Bank, DNB, JP Morgan and Nordea to investigate the possibilities of a larger bond issue.  For further information, please contact: Magnus Nordholm, Deputy CEO       +46 705-29 31 44      magnus.nordholm@heimstaden.com Adam Lindh, Director of Finance       +46 708-86 96 74      adam.

Duni acquires shares in BioPak Pty Ltd, the leading supplier of sustainable packaging in Australia and New Zealand

On October 15, 2018, Duni acquires 75% of BioPak Pty Ltd from entrepreneurs Gary Smith and Richard Fine. BioPak is a leading supplier of sustainable disposable packaging for the food service industry in Australia and New Zealand with an approximate annual turnover of SEK 385 m. The acquisition will be consolidated into Business Area New Markets starting mid-October 2018.BioPak was started in 2006 with the aim of offering the most sustainable, environmentally adapted packaging on the Australian market. Owing to a highly demanded assortment built on fibers, cardboard and bioplastics as well

UBS Europe SE completes acquisition of Nordea’s Luxembourg-based private banking business

UBS and Nordea announced today that UBS has successfully acquired part of Nordea's Luxembourg-based private banking business.As announced in January 2018, the transaction covers the acquisition of part of Nordea Bank’s business and its integration onto UBS' platform, thereby providing clients access to its global offering and local expertise. The decision followed a thorough strategic review of Nordea’s Private Banking International activities. The strategic review was part of the transformation of Nordea with the aim to better manage risk, focus on the core business and deliver an

Stora Enso shares converted

STORA ENSO OYJ STOCK EXCHANGE RELEASE 15 October 2018 at 9.00 EESTDuring the 1–28 September 2018 conversion period there was one conversion and a total of 55 A shares were converted into R shares. The shares were recorded in the Finnish trade register today, 15 October 2018, and trading in the new R shares will start on 16 October 2018.Breakdown of shares after conversion: A shares  176 326 992R shares  612 292 995Total  788 619 987 Each A share and each ten R shares carry one vote. The total amount of votes after the conversion is at least 237 556 291.For further

IRRAS EXPANDS ITS PRODUCT DEVELOPMENT AND MANUFACTURING TEAM IN THE U.S. WITH THE HIRING OF KEY TALENTED PROFESSIONALS

- Key new hires will support launch of IRRAflow® in the U.S. by year end 2018Stockholm, Sweden, October 15, 2018 – IRRAS AB (Nasdaq First North Premier: IRRAS) announced today that it has expanded its product development and manufacturing capabilities by hiring key top talents to the organization. Mr. Adam Sampson will lead production and manufacturing as Vice President of Product Excellence, and Mr. Dino De Cicco will serve as Senior Director, Product Development, in the United States. Collectively, Mr. Sampson and Mr. De Cicco have over 40 years of relevant medical device experience and

Konecranes wins port automation deal in the Middle East

Konecranes wins port automation deal in the Middle East Abu Dhabi Terminals (ADT) in Abu Dhabi, UAE, has selected Konecranes to be the supplier of an Automated Stacking Crane (ASC) system for the second phase of the building of its container terminal in Khalifa Port: the Khalifa Port Container Terminal (KPCT). This is an order for a total of 54 Automated Rail Mounted Gantry (ARMG) cranes. The parties involved have agreed not to disclose the value of the deal. The order will be booked in Q4 2018.Konecranes earlier successfully delivered 52 ARMG cranes, on time and on budget for the

Nexam Chemical automates and improve production efficiency in Lomma

Nexam Chemical has successfully completed an automatization project at the production plant in Lomma. The goal was to streamline production and to increase the capacity at the plant. The project has now been evaluated and the results exceed the expectations.The project is a consequence of the analysis that was made of the material flow in conjunction with the installation of the latest production line during the winter of 2017/2018. On this basis, the company decided to install two new robots, one is used for unloading raw materials from bags into the production line and the other for

Share buy-backs in Telia Company during week 41 2018

During the period  October 08, 2018 - October 12, 2018, Telia Company AB (publ) (LEI code 213800FSR9RNDUOTXO25) has repurchased in total 4 700 000 own shares (ISIN: SE0000667925). The share buy-backs form part of the SEK 5 billion share buy-back programme that Telia Company announced on April 20, 2018. The share buy-back programme, which runs between April 23, 2018 and March 22, 2019, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 ("MAR") and the Commission Delegated Regulation (EU) No 2016/1052 (the "Safe Harbour Regulation").During the period October

Skanska plans tunnel and station in Sundbyberg and Solna for the Swedish Transport Administration (Trafikverket) for about SEK 300M

Skanska Sweden has signed an agreement with Trafikverket to work out the prerequisites for implement the contract "E9961 Tunnel and Station Sundbyberg-Solna" in the infrastructure project Mälarbanan. The contract is worth SEK 300M, which will be included in the order bookings for Skanska Sweden in the fourth quarter of 2018.This first and preparatory phase begins in November and is scheduled to end in February 2021. Project Mälarbanan comprises the railway line between Tomteboda and Kallhäll, which will get four instead of two tracks.

There are no items matching the current filter
There are no more items matching the current filter
Back to top